The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Gelnique     4-diethylaminobut-2-ynyl 2-cyclohexyl-2...

Synonyms: Dridase, Gelinique, Tropax, Ditropan Xl, Prestwick_621, ...
This record was replaced with 4634.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Oxytrol


Psychiatry related information on Oxytrol


High impact information on Oxytrol


Chemical compound and disease context of Oxytrol


Analytical, diagnostic and therapeutic context of Oxytrol

  • Significant increases in voided volume (38% versus 53%; P <0.01) and total bladder capacity (55% versus 70%; P = 0.03), normalized for age-expected bladder capacity, occurred by the first clinic visit after beginning Ditropan XL [8].


  1. Is extended-release oxybutynin (Ditropan XL) or tolterodine (Detrol) more effective in the treatment of an overactive bladder? Hartnett, N.M., Saver, B.G. The Journal of family practice. (2001) [Pubmed]
  2. Oxybutynin chloride (Ditropan) in enuresis. Buttarazzi, P.J. J. Urol. (1977) [Pubmed]
  3. R and S enantiomers of oxybutynin: pharmacological effects in guinea pig bladder and intestine. Kachur, J.F., Peterson, J.S., Carter, J.P., Rzeszotarski, W.J., Hanson, R.C., Noronha-Blob, L. J. Pharmacol. Exp. Ther. (1988) [Pubmed]
  4. Effects of a beta2-agonist on airway hyperreactivity in subjects with cervical spinal cord injury. DeLuca, R.V., Grimm, D.R., Lesser, M., Bauman, W.A., Almenoff, P.L. Chest (1999) [Pubmed]
  5. A population pharmacokinetic model with time-dependent covariates measured with errors. Li, L., Lin, X., Brown, M.B., Gupta, S., Lee, K.H. Biometrics (2004) [Pubmed]
  6. A health related quality of life measure for use in patients with urge urinary incontinence: a validation study. Lubeck, D.P., Prebil, L.A., Peeples, P., Brown, J.S. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. (1999) [Pubmed]
  7. (S)-oxybutynin (Sepracor). Dmochowski, R.R. Current opinion in investigational drugs (London, England : 2000) (2002) [Pubmed]
  8. Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin. Van Arendonk, K.J., Knudson, M.J., Austin, J.C., Cooper, C.S. Urology (2006) [Pubmed]
WikiGenes - Universities